FeesSafety
Pluang+

Team, Inc. sets Q3 2026 earnings release for Nov 11 with conference call on Nov 12

Company Fundamentals
03 Nov 2026, 15:00 WIB
GlobeNewsWire
View Source
Neutral
Team, Inc. sets Q3 2026 earnings release for Nov 11 with conference call on Nov 12

Team, Inc., a global specialty industrial services provider, announced it will release its third quarter 2026 earnings on November 11 after NYSE trading closes. The company will hold a conference call to discuss results on November 12 at 8:00 a.m. Central Time, open to investors via phone and webcast. This event allows investors to hear financial updates and ask questions, reflecting Team's ongoing transparency and engagement with shareholders.

Team, Inc. announced its Q3 2026 earnings release and conference call dates. For readers following Industrials, here is Pluang's market snapshot as of Nov 03, 2026 18:42 WIB: Out of 135 Industrials stocks, 73 rose and 53 fell. TRMD rose 4.22% to USD 41.50 with 100% buy orders, FRO increased 2.76% to USD 53.52 also with 100% buy orders, while RELX fell 2.47% to USD 39.46.

More News

Automatic FOUP Opener Market to reach $6.04B by 2032 with 5.36% CAGR driven by fab automation and contamination control

Automatic FOUP Opener Market to reach $6.04B by 2032 with 5.36% CAGR driven by fab automation and contamination control

The global Automatic FOUP Opener Market is projected to grow from USD 4.41 billion in 2026 to USD 6.04 billion by 2032, expanding at a CAGR of 5.36%. Growth is driven by increasing fab automation, stricter contamination control requirements, and dema...

Market News
Bullish
21 minutes ago
Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology, a clinical-stage biotech company focusing on cancer therapies via PLK1 inhibition, announced it will present at the UBS Global Biopharma Conference on November 16-17, 2026. The company's CEO, Mani Mohindru, will deliver a fireside c...

Market News
Bullish
3 hours ago
Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex Life Sciences appointed Terrie Kellmeyer, Ph.D., as President and CEO, also joining the Board. Kellmeyer, with over 30 years in biopharma, has led the company through key clinical milestones including FDA clearance for Fragile X syndrome trial...

Company Fundamentals
Bullish
3 hours ago
Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond Inc is enhancing its smart city solutions by integrating advanced LiDAR 3D sensing with AI-powered analytics and collaborations with Dell Technologies, NVIDIA, and AMSYS. This expansion supports improved safety, transportation, and infrastruct...

Market News
Bullish
3 hours ago
Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones Inc. announced a teleconference on November 4, 2026, at 10:00 AM EST to discuss its third-quarter 2026 financial results. The event is open to investors, analysts, and interested parties, with live streaming and phone access provided. A ...

Company Fundamentals
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App